Jingyi Meng
Biographic Data
| ID | 7782296 |
|---|---|
| NAME | Jingyi Meng |
| GIVEN NAMES | Jingyi |
| FAMILY NAME | Meng |
| SIGNATURE | MENG J |
| AFFILIATIONS | Nantong University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Preferences for public health insurance coverage of new anticancer drugs
Health insurance policymakers need to consider the affordability, comparative survival benefits, comparative safety, and comparative patient-reported outcomes of new anticancer drugs. The findings also highlight the need to ensure affordability for older patients, low-income patients, and patients with advanced cancer
Assessing patient information needs for new antidiabetic medications to inform shared decision‐making
BACKGROUND: Shared decision-making (SDM) is a patient-centred approach to improve the quality of care. An essential requirement for the SDM process is to be fully aware of patient information needs. OBJECTIVES: Our study aimed to assess patient information needs for new antidiabetic medications using the best-worst scaling (BWS) experiment. METHODS: BWS tasks were developed according to a literature review and the focus group discussion. We used …
Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions
The new anti-diabetic drugs with significant clinical effectiveness and long-term health benefits should become the priority for public health insurance. The findings also highlight the value of accounting for preference heterogeneity in insurance policy-making
No prominent works on this page.
Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions
The new anti-diabetic drugs with significant clinical effectiveness and long-term health benefits should become the priority for public health insurance. The findings also highlight the value of accounting for preference heterogeneity in insurance policy-making
Assessing patient information needs for new antidiabetic medications to inform shared decision‐making
BACKGROUND: Shared decision-making (SDM) is a patient-centred approach to improve the quality of care. An essential requirement for the SDM process is to be fully aware of patient information needs. OBJECTIVES: Our study aimed to assess patient information needs for new antidiabetic medications using the best-worst scaling (BWS) experiment. METHODS: BWS tasks were developed according to a literature review and the focus group discussion. We used …
Preferences for public health insurance coverage of new anticancer drugs
Health insurance policymakers need to consider the affordability, comparative survival benefits, comparative safety, and comparative patient-reported outcomes of new anticancer drugs. The findings also highlight the need to ensure affordability for older patients, low-income patients, and patients with advanced cancer
China (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Medicine (3 works) · Actuarial science (2 works) · Biostatistics (2 works) · Economic and Environmental Valuation (2 works) · Economic growth (2 works) · Environmental health (2 works) · Epidemiology (2 works) · Health care (2 works)